David Levine

David Levine (@dlloydlevine) is co-chairman of Science Writers in New York and a member the National Association of Science Writers and the Association of Health Care Journalists. He writes for The New York Times, Reuters Health, Scientific American Mind, Nature Medicine, the Los Angeles Times, Nautilus, and the Smithsonian.

Latest by David Levine

Aggressive Prostate Cancer and Low Vitamin D
Risk Factors

Aggressive Prostate Cancer and Low Vitamin D

Lower levels of vitamin D are linked to an increased risk of aggressive prostate cancer. Learn what that could mean for your prostate health.

Active Surveillance for Prostate Cancer: When Is It Risky?

Active Surveillance for Prostate Cancer?

Should men with intermediate-risk prostate cancer be offered active surveillance as a treatment? Learn what new research suggests.

Costs to Treat Low-Risk Prostate Cancer Vary

Costs of Low-Risk Prostate Cancer Treatments

If you're a man with low-risk prostate cancer, consider this study that found a significant cost variation among competing prostate treatments.